SECOND GENERATION GRP94-SELECTIVE INHIBITORS

• 收藏
• 分享

专利权人:

University of Kansas

发明人:

Brian S.J. Blagg,Vincent Matthew Crowley

申请号：

US16640897

公开号：

US20200190017A1

申请日:

2018.08.23

申请国别(地区):

US

年份:

2020

代理人:

摘要：

The present technology provides compounds selective for the Grp94 isoform, as well as compositions including such compounds, that are useful for treatment of multiple myeloma, melanoma, lung cancer, hepatocellular carcinoma, breast cancer, prostate cancer, and/or glaucoma. Methods using the compounds are also provided.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/